{"pmid":32331291,"title":"Human Interaction Smart Subsystem-Extending Speech-Based Human-Robot Interaction Systems with an Implementation of External Smart Sensors.","text":["Human Interaction Smart Subsystem-Extending Speech-Based Human-Robot Interaction Systems with an Implementation of External Smart Sensors.","This paper presents a more detailed concept of Human-Robot Interaction systems architecture. One of the main differences between the proposed architecture and other ones is the methodology of information acquisition regarding the robot's interlocutor. In order to obtain as much information as possible before the actual interaction took place, a custom Internet-of-Things-based sensor subsystems connected to Smart Infrastructure was designed and implemented, in order to support the interlocutor identification and acquisition of initial interaction parameters. The Artificial Intelligence interaction framework of the developed robotic system (including humanoid Pepper with its sensors and actuators, additional local, remote and cloud computing services) is being extended with the use of custom external subsystems for additional knowledge acquisition: device-based human identification, visual identification and audio-based interlocutor localization subsystems. These subsystems were deeply introduced and evaluated in this paper, presenting the benefits of integrating them into the robotic interaction system. In this paper a more detailed analysis of one of the external subsystems-Bluetooth Human Identification Smart Subsystem-was also included. The idea, use case, and a prototype, integration of elements of Smart Infrastructure systems and the prototype implementation were performed in a small front office of the Weegree company as a decent test-bed application area.","Sensors (Basel)","Podpora, Michal","Gardecki, Arkadiusz","Beniak, Ryszard","Klin, Bartlomiej","Vicario, Jose Lopez","Kawala-Sterniuk, Aleksandra","32331291"],"abstract":["This paper presents a more detailed concept of Human-Robot Interaction systems architecture. One of the main differences between the proposed architecture and other ones is the methodology of information acquisition regarding the robot's interlocutor. In order to obtain as much information as possible before the actual interaction took place, a custom Internet-of-Things-based sensor subsystems connected to Smart Infrastructure was designed and implemented, in order to support the interlocutor identification and acquisition of initial interaction parameters. The Artificial Intelligence interaction framework of the developed robotic system (including humanoid Pepper with its sensors and actuators, additional local, remote and cloud computing services) is being extended with the use of custom external subsystems for additional knowledge acquisition: device-based human identification, visual identification and audio-based interlocutor localization subsystems. These subsystems were deeply introduced and evaluated in this paper, presenting the benefits of integrating them into the robotic interaction system. In this paper a more detailed analysis of one of the external subsystems-Bluetooth Human Identification Smart Subsystem-was also included. The idea, use case, and a prototype, integration of elements of Smart Infrastructure systems and the prototype implementation were performed in a small front office of the Weegree company as a decent test-bed application area."],"journal":"Sensors (Basel)","authors":["Podpora, Michal","Gardecki, Arkadiusz","Beniak, Ryszard","Klin, Bartlomiej","Vicario, Jose Lopez","Kawala-Sterniuk, Aleksandra"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32331291","week":"202017|Apr 20 - Apr 26","doi":"10.3390/s20082376","keywords":["covid-19","cloud services","humanoid robots","pepper robot","sensor networks","smart infrastructure","thermal imaging"],"source":"PubMed","weight":0,"_version_":1665071049798057985,"score":8.518259,"similar":[{"pmid":32235517,"title":"Healthcare Digitalization and Pay-For-Performance Incentives in Smart Hospital Project Financing.","text":["Healthcare Digitalization and Pay-For-Performance Incentives in Smart Hospital Project Financing.","This study aims to explore the impact of healthcare digitalization on smart hospital project financing (PF) fostered by pay-for-performance (P4P) incentives. Digital platforms are a technology-enabled business model that facilitates exchanges between interacting agents. They represent a bridging link among disconnected nodes, improving the scalable value of networks. Application to healthcare public-private partnerships (PPPs) is significant due to the consistency of digital platforms with health issues and the complexity of the stakeholder's interaction. In infrastructural PPPs, public and private players cooperate, usually following PF patterns. This relationship is complemented by digitized supply chains and is increasingly patient-centric. This paper reviews the literature, analyzes some supply chain bottlenecks, addresses solutions concerning the networking effects of platforms to improve PPP interactions, and investigates the cost-benefit analysis of digital health with an empirical case. Whereas diagnostic or infrastructural technology is an expensive investment with long-term payback, leapfrogging digital applications reduce contingent costs. \"Digital\" savings can be shared by key stakeholders with P4P schemes, incentivizing value co-creation patterns. Efficient sharing may apply network theory to a comprehensive PPP ecosystem where stakeholding nodes are digitally connected. This innovative approach improves stakeholder relationships, which are re-engineered around digital platforms that enhance patient-centered satisfaction and sustainability. Digital technologies are useful even for infectious disease surveillance, like that of the coronavirus pandemic, for supporting massive healthcare intervention, decongesting hospitals, and providing timely big data.","Int J Environ Res Public Health","Moro Visconti, Roberto","Morea, Donato","32235517"],"abstract":["This study aims to explore the impact of healthcare digitalization on smart hospital project financing (PF) fostered by pay-for-performance (P4P) incentives. Digital platforms are a technology-enabled business model that facilitates exchanges between interacting agents. They represent a bridging link among disconnected nodes, improving the scalable value of networks. Application to healthcare public-private partnerships (PPPs) is significant due to the consistency of digital platforms with health issues and the complexity of the stakeholder's interaction. In infrastructural PPPs, public and private players cooperate, usually following PF patterns. This relationship is complemented by digitized supply chains and is increasingly patient-centric. This paper reviews the literature, analyzes some supply chain bottlenecks, addresses solutions concerning the networking effects of platforms to improve PPP interactions, and investigates the cost-benefit analysis of digital health with an empirical case. Whereas diagnostic or infrastructural technology is an expensive investment with long-term payback, leapfrogging digital applications reduce contingent costs. \"Digital\" savings can be shared by key stakeholders with P4P schemes, incentivizing value co-creation patterns. Efficient sharing may apply network theory to a comprehensive PPP ecosystem where stakeholding nodes are digitally connected. This innovative approach improves stakeholder relationships, which are re-engineered around digital platforms that enhance patient-centered satisfaction and sustainability. Digital technologies are useful even for infectious disease surveillance, like that of the coronavirus pandemic, for supporting massive healthcare intervention, decongesting hospitals, and providing timely big data."],"journal":"Int J Environ Res Public Health","authors":["Moro Visconti, Roberto","Morea, Donato"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32235517","week":"202014|Mar 30 - Apr 05","doi":"10.3390/ijerph17072318","keywords":["coronavirus","digital innovation","healthcare bottlenecks","healthcare sustainable development","internet of medical things","mhealth","patient-centered care","public-private partnerships","results-based-financing"],"source":"PubMed","weight":0,"_version_":1664638354332844032,"score":169.08308},{"pmid":32260436,"title":"Wearable Cardiorespiratory Monitoring Employing a Multimodal Digital Patch Stethoscope: Estimation of ECG, PEP, LVETand Respiration Using a 55 mm Single-Lead ECG and Phonocardiogram.","text":["Wearable Cardiorespiratory Monitoring Employing a Multimodal Digital Patch Stethoscope: Estimation of ECG, PEP, LVETand Respiration Using a 55 mm Single-Lead ECG and Phonocardiogram.","Cardiovascular diseases are the main cause of death worldwide, with sleep disordered breathing being a further aggravating factor. Respiratory illnesses are the third leading cause of death amongst the noncommunicable diseases. The current COVID-19 pandemic, however, also highlights the impact of communicable respiratory syndromes. In the clinical routine, prolonged postanesthetic respiratory instability worsens the patient outcome. Even though early and continuous, long-term cardiorespiratory monitoring has been proposed or even proven to be beneficial in several situations, implementations thereof are sparse. We employed our recently presented, multimodal patch stethoscope to estimate Einthoven electrocardiogram (ECG) Lead I and II from a single 55 mm ECG lead. Using the stethoscope and ECG subsystems, the pre-ejection period (PEP) and left ventricular ejection time (LVET) were estimated. ECG-derived respiration techniques were used in conjunction with a novel, phonocardiogram-derived respiration approach to extract respiratory parameters. Medical-grade references were the SOMNOmedics SOMNO HD(TM) and Osypka ICON-Core(TM). In a study including 10 healthy subjects, we analyzed the performances in the supine, lateral, and prone position. Einthoven I and II estimations yielded correlations exceeding 0.97. LVET and PEP estimation errors were 10% and 21%, respectively. Respiratory rates were estimated with mean absolute errors below 1.2 bpm, and the respiratory signal yielded a correlation of 0.66. We conclude that the estimation of ECG, PEP, LVET, and respiratory parameters is feasible using a wearable, multimodal acquisition device and encourage further research in multimodal signal fusion for respiratory signal estimation.","Sensors (Basel)","Klum, Michael","Urban, Mike","Tigges, Timo","Pielmus, Alexandru-Gabriel","Feldheiser, Aarne","Schmitt, Theresa","Orglmeister, Reinhold","32260436"],"abstract":["Cardiovascular diseases are the main cause of death worldwide, with sleep disordered breathing being a further aggravating factor. Respiratory illnesses are the third leading cause of death amongst the noncommunicable diseases. The current COVID-19 pandemic, however, also highlights the impact of communicable respiratory syndromes. In the clinical routine, prolonged postanesthetic respiratory instability worsens the patient outcome. Even though early and continuous, long-term cardiorespiratory monitoring has been proposed or even proven to be beneficial in several situations, implementations thereof are sparse. We employed our recently presented, multimodal patch stethoscope to estimate Einthoven electrocardiogram (ECG) Lead I and II from a single 55 mm ECG lead. Using the stethoscope and ECG subsystems, the pre-ejection period (PEP) and left ventricular ejection time (LVET) were estimated. ECG-derived respiration techniques were used in conjunction with a novel, phonocardiogram-derived respiration approach to extract respiratory parameters. Medical-grade references were the SOMNOmedics SOMNO HD(TM) and Osypka ICON-Core(TM). In a study including 10 healthy subjects, we analyzed the performances in the supine, lateral, and prone position. Einthoven I and II estimations yielded correlations exceeding 0.97. LVET and PEP estimation errors were 10% and 21%, respectively. Respiratory rates were estimated with mean absolute errors below 1.2 bpm, and the respiratory signal yielded a correlation of 0.66. We conclude that the estimation of ECG, PEP, LVET, and respiratory parameters is feasible using a wearable, multimodal acquisition device and encourage further research in multimodal signal fusion for respiratory signal estimation."],"journal":"Sensors (Basel)","authors":["Klum, Michael","Urban, Mike","Tigges, Timo","Pielmus, Alexandru-Gabriel","Feldheiser, Aarne","Schmitt, Theresa","Orglmeister, Reinhold"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32260436","week":"202015|Apr 06 - Apr 12","doi":"10.3390/s20072033","keywords":["ecg","ecg-derived respiration","lvet","pep","digital stethoscope","neural network","patch","phonocardiogram-derived respiration","respiration rate","wearable cardiorespiratory monitoring"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664637636115955713,"score":164.55106},{"pmid":32313361,"pmcid":"PMC7167562","title":"Smart technologies for fighting pandemics: The techno- and human- driven approaches in controlling the virus transmission.","text":["Smart technologies for fighting pandemics: The techno- and human- driven approaches in controlling the virus transmission.","How do governments in China and Western democracies differ in their technological response to control the transmission of the pandemic? Based on an analysis of academic papers, World Health Organization reports and newspapers, this research compares two opposing approaches, whereas the Chinese cities and government have adopted a techno-driven approach, Western governments have adopted a human-driven approach to control the transmission of Covid-19. The findings highlight that although the techno driven approach may be more productive to identify, isolate and quarantine infected individuals, it also results in the suppression and censoring the citizen views. It is further emphasized that human interaction with the technology is mediated by the political and institutional context in which the technologies are implemented. This paper contributes to literature by understanding the human-technology relationship, and offers five practical observations for controlling virus transmissions during pandemics.","Gov Inf Q","Kummitha, Rama Krishna Reddy","32313361"],"abstract":["How do governments in China and Western democracies differ in their technological response to control the transmission of the pandemic? Based on an analysis of academic papers, World Health Organization reports and newspapers, this research compares two opposing approaches, whereas the Chinese cities and government have adopted a techno-driven approach, Western governments have adopted a human-driven approach to control the transmission of Covid-19. The findings highlight that although the techno driven approach may be more productive to identify, isolate and quarantine infected individuals, it also results in the suppression and censoring the citizen views. It is further emphasized that human interaction with the technology is mediated by the political and institutional context in which the technologies are implemented. This paper contributes to literature by understanding the human-technology relationship, and offers five practical observations for controlling virus transmissions during pandemics."],"journal":"Gov Inf Q","authors":["Kummitha, Rama Krishna Reddy"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32313361","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.giq.2020.101481","keywords":["covid-19","human-driven","pandemic","privacy","smart cities","smart technologies","techno-driven"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["China","Western","Chinese","Western"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664714520211226624,"score":157.09988},{"pmid":32305937,"title":"Review of Artificial Intelligence Techniques in Imaging Data Acquisition, Segmentation and Diagnosis for COVID-19.","text":["Review of Artificial Intelligence Techniques in Imaging Data Acquisition, Segmentation and Diagnosis for COVID-19.","The pandemic of coronavirus disease 2019 (COVID-19) is spreading all over the world. Medical imaging such as X-ray and computed tomography (CT) plays an essential role in the global fight against COVID-19, whereas the recently emerging artificial intelligence (AI) technologies further strengthen the power of the imaging tools and help medical specialists. We hereby review the rapid responses in the community of medical imaging (empowered by AI) toward COVID-19. For example, AI-empowered image acquisition can significantly help automate the scanning procedure and also reshape the workflow with minimal contact to patients, providing the best protection to the imaging technicians. Also, AI can improve work efficiency by accurate delineation of infections in X-ray and CT images, facilitating subsequent quantification. Moreover, the computer-aided platforms help radiologists make clinical decisions, i.e., for disease diagnosis, tracking, and prognosis. In this review paper, we thus cover the entire pipeline of medical imaging and analysis techniques involved with COVID-19, including image acquisition, segmentation, diagnosis, and follow-up. We particularly focus on the integration of AI with X-ray and CT, both of which are widely used in the frontline hospitals, in order to depict the latest progress of medical imaging and radiology fighting against COVID-19.","IEEE Rev Biomed Eng","Shi, Feng","Wang, Jun","Shi, Jun","Wu, Ziyan","Wang, Qian","Tang, Zhenyu","He, Kelei","Shi, Yinghuan","Shen, Dinggang","32305937"],"abstract":["The pandemic of coronavirus disease 2019 (COVID-19) is spreading all over the world. Medical imaging such as X-ray and computed tomography (CT) plays an essential role in the global fight against COVID-19, whereas the recently emerging artificial intelligence (AI) technologies further strengthen the power of the imaging tools and help medical specialists. We hereby review the rapid responses in the community of medical imaging (empowered by AI) toward COVID-19. For example, AI-empowered image acquisition can significantly help automate the scanning procedure and also reshape the workflow with minimal contact to patients, providing the best protection to the imaging technicians. Also, AI can improve work efficiency by accurate delineation of infections in X-ray and CT images, facilitating subsequent quantification. Moreover, the computer-aided platforms help radiologists make clinical decisions, i.e., for disease diagnosis, tracking, and prognosis. In this review paper, we thus cover the entire pipeline of medical imaging and analysis techniques involved with COVID-19, including image acquisition, segmentation, diagnosis, and follow-up. We particularly focus on the integration of AI with X-ray and CT, both of which are widely used in the frontline hospitals, in order to depict the latest progress of medical imaging and radiology fighting against COVID-19."],"journal":"IEEE Rev Biomed Eng","authors":["Shi, Feng","Wang, Jun","Shi, Jun","Wu, Ziyan","Wang, Qian","Tang, Zhenyu","He, Kelei","Shi, Yinghuan","Shen, Dinggang"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32305937","week":"202017|Apr 20 - Apr 26","doi":"10.1109/RBME.2020.2987975","source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664641855735726081,"score":144.7901},{"pmid":32293168,"title":"Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor.","text":["Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor.","Coronavirus disease 2019 (COVID-19) is a newly emerging human infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously called 2019-nCoV). Based on the rapid increase in the rate of human infection, the World Health Organization (WHO) has classified the COVID-19 outbreak as a pandemic. Because no specific drugs or vaccines for COVID-19 are yet available, early diagnosis and management are crucial for containing the outbreak. Here, we report a field-effect transistor (FET)-based biosensing device for detecting SARS-CoV-2 in clinical samples. The sensor was produced by coating graphene sheets of the FET with a specific antibody against SARS-CoV-2 spike protein. The performance of the sensor was determined using antigen protein, cultured virus, and nasopharyngeal swab specimens from COVID-19 patients. Our FET device could detect the SARS-CoV-2 spike protein at concentrations of 1 fg/mL in phosphate-buffered saline and 100 fg/mL clinical transport medium. In addition, the FET sensor successfully detected SARS-CoV-2 in culture medium (limit of detection [LOD]: 1.6 x 10(1) pfu/mL) and clinical samples (LOD: 2.42 x 10(2) copies/mL). Thus, we have successfully fabricated a promising FET biosensor for SARS-CoV-2; our device is a highly sensitive immunological diagnostic method for COVID-19 that requires no sample pretreatment or labeling.","ACS Nano","Seo, Giwan","Lee, Geonhee","Kim, Mi Jeong","Baek, Seung-Hwa","Choi, Minsuk","Ku, Keun Bon","Lee, Chang-Seop","Jun, Sangmi","Park, Daeui","Kim, Hong Gi","Kim, Seong-Jun","Lee, Jeong-O","Kim, Bum Tae","Park, Edmond Changkyun","Kim, Seung Il","32293168"],"abstract":["Coronavirus disease 2019 (COVID-19) is a newly emerging human infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously called 2019-nCoV). Based on the rapid increase in the rate of human infection, the World Health Organization (WHO) has classified the COVID-19 outbreak as a pandemic. Because no specific drugs or vaccines for COVID-19 are yet available, early diagnosis and management are crucial for containing the outbreak. Here, we report a field-effect transistor (FET)-based biosensing device for detecting SARS-CoV-2 in clinical samples. The sensor was produced by coating graphene sheets of the FET with a specific antibody against SARS-CoV-2 spike protein. The performance of the sensor was determined using antigen protein, cultured virus, and nasopharyngeal swab specimens from COVID-19 patients. Our FET device could detect the SARS-CoV-2 spike protein at concentrations of 1 fg/mL in phosphate-buffered saline and 100 fg/mL clinical transport medium. In addition, the FET sensor successfully detected SARS-CoV-2 in culture medium (limit of detection [LOD]: 1.6 x 10(1) pfu/mL) and clinical samples (LOD: 2.42 x 10(2) copies/mL). Thus, we have successfully fabricated a promising FET biosensor for SARS-CoV-2; our device is a highly sensitive immunological diagnostic method for COVID-19 that requires no sample pretreatment or labeling."],"journal":"ACS Nano","authors":["Seo, Giwan","Lee, Geonhee","Kim, Mi Jeong","Baek, Seung-Hwa","Choi, Minsuk","Ku, Keun Bon","Lee, Chang-Seop","Jun, Sangmi","Park, Daeui","Kim, Hong Gi","Kim, Seong-Jun","Lee, Jeong-O","Kim, Bum Tae","Park, Edmond Changkyun","Kim, Seung Il"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32293168","week":"202016|Apr 13 - Apr 19","doi":"10.1021/acsnano.0c02823","keywords":["2019-ncov","covid-19","fet","sars-cov-2","biosensor"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"e_drugs":["Lead","Graphite"],"_version_":1664636192516210688,"score":144.22429}]}